Inventor
JOHN ANDREW CHRISTOPHER
Inventor
GB
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes26%
C07CAcyclic or carbocyclic compounds5%
PatentTitleYear
12,415,7954-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators202512,344,621CGRP antagonist compounds202512,331,029Orexin 1 receptor antagonists202512,240,825Oxexin 1 receptor antagonists202512,178,813CGRP receptor antagonists202411,680,053Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators202311,584,732Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to HEPTARES THERAPEUTICS LTD (3)· patent assignee history
2023–2025Based in GB· patent location history
2024–2025Patents assigned to NXERA PHARMA UK LTD (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NXERA PHARMA UK LTD | 5 | 2024–2025 |
| HEPTARES THERAPEUTICS LTD | 3 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 7 | 2023–2025 |